Skip to content

Feasibility Study: Ulthera Treatment of the Buttocks and Thighs

Feasibility Study: Evaluation of the Ulthera® System for Lifting and Tightening the Buttocks and Thighs

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01708460
Enrollment
31
Registered
2012-10-17
Start date
2011-12-31
Completion date
2013-07-31
Last updated
2017-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Laxity

Keywords

Ulthera® System, Ultherapy™ Treatment, Ulthera, Inc., Ultrasound treatment for skin tightening

Brief summary

Up to 30 subjects will be enrolled. Enrolled subjects will receive an Ulthera® treatment to one side of the body, treating the lateral buttock region. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.

Detailed description

This is a prospective, single-center, pilot clinical trial to evaluate the efficacy of the Ulthera® System to improve buttock and thigh skin laxity. Global Aesthetic Improvement Scale scores and patient satisfaction questionnaires will be obtained.

Interventions

Focused ultrasound energy delivered below the surface of the skin.

Sponsors

Ulthera, Inc
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female, age 30 to 65 years. * Subject in good health. * Skin laxity in the buttocks and thighs. * Understands and accepts the obligation not to undergo any other procedures in the areas to be treated and/or weight loss through the follow-up period. * Willingness and ability to comply with protocol requirements, including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study. * Subjects of childbearing potential must have a negative urine pregnancy test result and must not be lactating at Visit 1 and be willing and able to use an acceptable method of birth control (e.g., barrier methods used with a spermicidal agent, hormonal methods, IUD, surgical sterilization, abstinence) during the study. Women will not be considered of childbearing potential if one of the following conditions is documented on the medical history: a) Postmenopausal for at least 12 months prior to study; b) Without a uterus and/or both ovaries; or c) A bilateral tubal ligation at least six months prior to study enrollment.

Exclusion criteria

* Presence of an active systemic or local skin disease that may affect wound healing. * BMI equal to or greater than 40. * Excessive subcutaneous fat in the buttocks and thighs. * Excessive skin laxity in the buttocks and thighs. * Significant weight fluctuation (±10 lbs) in the past 6 months. * Taking weight-loss medications/supplements. * Surgical or non-surgical treatments to the target areas in the last 12 months, e.g., liposuction. * Inability to understand the protocol or to give informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Overall lifting and tightening of the buttocks and thighs.90 days post-treatmentAs determined by a masked, qualitative assessment of photographs at three months post-treatment compared to baseline.

Secondary

MeasureTime frameDescription
Overall aesthetic improvement.90 and 180 days post-treatment.As determined by GAIS completed by the Investigator and subject.
Overall subject satisfaction.90 and 180 days post-treatmentAs determined by subjects' completion of a Patient Satisfaction Questionnaire.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026